BioSpace News Archive

Drug Development

ASCO15: Calithera Biosciences, Inc. Reports Phase I Data For CB-839 In Patients With Solid Tumors At The 2015 ASCO

June 1, 2015
·
6 min read
Drug Development

Astellas Pharma Inc. Announces Preliminary Phase 1/2 Safety, Tolerability And Efficacy Data For ASP2215 In Patients With Relapsed Or Refractory Acute Myeloid Leukemia (AML)

June 1, 2015
·
3 min read
Stempeutics Receives Orphan Drug Designation (ODD) In The European Union For Its Novel Stem Cell Drug “Stempeucel” For The Treatment Of Thromboangiitis Obliterans

June 1, 2015
·
5 min read
The Ontario Institute for Cancer Research Invests $4.6 Million To Support Pancreatic Cancer Research

June 1, 2015
·
4 min read
Business

Cancer Treatment Centers Of America Medicine & Science Names Rodney Huebbers Chief Operating Officer

June 1, 2015
·
2 min read
BioCapital

Personal Genome Diagnostics Launches ImmunoSelect-R For Identification Of Immunogenic Cancer Mutations To Support Immuno-Oncology Drug Development

June 1, 2015
·
7 min read
Drug Development

ASCO15: VBL Therapeutics Reports Updated Interim Results From Phase II Clinical Trial Of VB-111 In Recurrent Glioblastoma (Rgbm)

June 1, 2015
·
7 min read
Drug Development

ASCO15: Onconova Therapeutics Inc. Presents Clinical Data On Rigosertib In Higher-Risk Myelodysplastic Syndromes (HR-MDS) At The 2015 ASCO Annual Meeting

June 1, 2015
·
7 min read
Business

Ivor Macleod Appointed Senior Vice President, Chief Financial Officer And Chief Compliance Officer Of Eisai Inc.

June 1, 2015
·
3 min read
BioCapital

Synthetic Biologics, Inc. To Host Microbiome Analyst & Investor Meeting

June 1, 2015
·
2 min read